EA201491614A1 - Способ лечения гинекологических заболеваний - Google Patents
Способ лечения гинекологических заболеванийInfo
- Publication number
- EA201491614A1 EA201491614A1 EA201491614A EA201491614A EA201491614A1 EA 201491614 A1 EA201491614 A1 EA 201491614A1 EA 201491614 A EA201491614 A EA 201491614A EA 201491614 A EA201491614 A EA 201491614A EA 201491614 A1 EA201491614 A1 EA 201491614A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- gynecological diseases
- treating gynecological
- pharmaceutical composition
- receptor modulator
- progesterone receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Изобретение относится главным образом к комбинации для применения при лечении гинекологических заболеваний и сопутствующих им инвалидизирующих симптомов у субъекта, нуждающегося в этом, где фармацевтическая комбинация для применения включает в себя совместное введение подходящей фармацевтической композиции для перорального приема, содержащей первый модулятор прогестероновых рецепторов, и фармацевтической композиции, пригодной для вагинального и/или внутриматочного введения, содержащей второй модулятор прогестероновых рецепторов.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261614785P | 2012-03-23 | 2012-03-23 | |
EP12160956.4A EP2641602A1 (en) | 2012-03-23 | 2012-03-23 | Method for treating gynecological diseases |
PCT/IB2013/052274 WO2013140372A1 (en) | 2012-03-23 | 2013-03-22 | Method for treating gynecological diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201491614A1 true EA201491614A1 (ru) | 2015-01-30 |
EA031488B1 EA031488B1 (ru) | 2019-01-31 |
Family
ID=45976689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201491614A EA031488B1 (ru) | 2012-03-23 | 2013-03-22 | Способ лечения гинекологических заболеваний |
Country Status (18)
Country | Link |
---|---|
US (1) | US10441534B2 (ru) |
EP (3) | EP2641602A1 (ru) |
JP (2) | JP2015514700A (ru) |
KR (1) | KR20140138824A (ru) |
CN (1) | CN104203246A (ru) |
AU (1) | AU2013236960B2 (ru) |
CA (1) | CA2864073A1 (ru) |
CO (1) | CO7111317A2 (ru) |
EA (1) | EA031488B1 (ru) |
GE (1) | GEP201706696B (ru) |
HK (1) | HK1199827A1 (ru) |
MX (1) | MX369520B (ru) |
MY (1) | MY172530A (ru) |
NZ (1) | NZ630011A (ru) |
SG (1) | SG11201404921QA (ru) |
TW (2) | TW201400121A (ru) |
WO (1) | WO2013140372A1 (ru) |
ZA (1) | ZA201407575B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11110103B2 (en) | 2015-12-23 | 2021-09-07 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
US11208432B2 (en) | 2015-12-23 | 2021-12-28 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
US11124537B2 (en) | 2015-12-23 | 2021-09-21 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
WO2017165707A1 (en) * | 2016-03-24 | 2017-09-28 | Juniper Pharmaceuticals, Inc. | Vaginal administration of agents for treating and preventing pain associated with gynecological medical procedures |
CN111690031B (zh) | 2016-10-07 | 2021-06-01 | 欧瑞克制药公司 | 糖皮质激素受体抑制剂 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3545439A (en) | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
US3920805A (en) | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
US4155991A (en) | 1974-10-18 | 1979-05-22 | Schering Aktiengesellschaft | Vaginal ring |
IL48277A (en) | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
US3995633A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal Medicament dispensing device |
US3991760A (en) | 1975-12-02 | 1976-11-16 | The Procter & Gamble Company | Vaginal medicament dispensing means |
US3995634A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal cavity dispensing means and method |
US4286587A (en) | 1978-10-11 | 1981-09-01 | Alza Corporation | Vaginal drug delivery system made from polymer |
US4292965A (en) | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
US4250611A (en) | 1979-04-19 | 1981-02-17 | Alza Corporation | Process for making drug delivery device with reservoir |
US4596576A (en) | 1984-10-12 | 1986-06-24 | Akzo N.V. | Release system for two or more active substances |
NL8500470A (nl) | 1985-02-19 | 1986-09-16 | Achel Homesteel Pvba | Intravaginaal orgaan. |
US4954490A (en) | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
FI95768C (fi) | 1993-06-17 | 1996-03-25 | Leiras Oy | Emättimensisäinen antosysteemi |
US5929262A (en) | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
US5972372A (en) | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
ES2212912B1 (es) | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
WO2004078709A2 (en) | 2003-02-28 | 2004-09-16 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | METHOD FOR PREPARING 17 α-ACETOXY-11β-(4-N,N-DIMETHYLAMINOPHENYL)-19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES THEREOF, AND METHODS FOR THE PREPARATION OF SUCH INTERMEDIATES |
ES2360806T3 (es) | 2004-07-09 | 2011-06-09 | The Population Council, Inc. | Composiciones de liberación prolongada que contienen moduladores de receptores de progesterona. |
WO2008129396A2 (en) * | 2007-04-20 | 2008-10-30 | Preglem S.A. | Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding |
US8299050B2 (en) * | 2008-01-29 | 2012-10-30 | Laboratoire Hra-Pharma | Method for treating uterine fibroids |
DK2249757T3 (en) * | 2008-02-04 | 2017-10-16 | Ferring Bv | Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof. |
-
2012
- 2012-03-23 EP EP12160956.4A patent/EP2641602A1/en not_active Withdrawn
-
2013
- 2013-03-22 TW TW102110291A patent/TW201400121A/zh unknown
- 2013-03-22 US US14/386,726 patent/US10441534B2/en not_active Expired - Fee Related
- 2013-03-22 CA CA2864073A patent/CA2864073A1/en not_active Abandoned
- 2013-03-22 NZ NZ630011A patent/NZ630011A/en not_active IP Right Cessation
- 2013-03-22 EA EA201491614A patent/EA031488B1/ru not_active IP Right Cessation
- 2013-03-22 CN CN201380014168.1A patent/CN104203246A/zh active Pending
- 2013-03-22 AU AU2013236960A patent/AU2013236960B2/en not_active Ceased
- 2013-03-22 MX MX2014011487A patent/MX369520B/es active IP Right Grant
- 2013-03-22 MY MYPI2014002228A patent/MY172530A/en unknown
- 2013-03-22 JP JP2015501044A patent/JP2015514700A/ja active Pending
- 2013-03-22 SG SG11201404921QA patent/SG11201404921QA/en unknown
- 2013-03-22 KR KR1020147027575A patent/KR20140138824A/ko not_active Application Discontinuation
- 2013-03-22 EP EP17192417.8A patent/EP3363500A1/en not_active Withdrawn
- 2013-03-22 WO PCT/IB2013/052274 patent/WO2013140372A1/en active Application Filing
- 2013-03-22 GE GEAP201313608A patent/GEP201706696B/en unknown
- 2013-03-22 EP EP13721095.1A patent/EP2827873A1/en not_active Ceased
- 2013-03-22 TW TW107104368A patent/TW201832767A/zh unknown
-
2014
- 2014-10-17 ZA ZA2014/07575A patent/ZA201407575B/en unknown
- 2014-10-20 CO CO14231832A patent/CO7111317A2/es unknown
-
2015
- 2015-01-12 HK HK15100309.9A patent/HK1199827A1/xx unknown
-
2018
- 2018-02-13 JP JP2018023604A patent/JP2018109025A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA201407575B (en) | 2015-12-23 |
EA031488B1 (ru) | 2019-01-31 |
EP2641602A1 (en) | 2013-09-25 |
EP2827873A1 (en) | 2015-01-28 |
MX2014011487A (es) | 2015-01-12 |
HK1199827A1 (en) | 2015-07-24 |
KR20140138824A (ko) | 2014-12-04 |
US10441534B2 (en) | 2019-10-15 |
WO2013140372A1 (en) | 2013-09-26 |
JP2018109025A (ja) | 2018-07-12 |
AU2013236960A1 (en) | 2014-09-25 |
GEP201706696B (en) | 2017-07-10 |
TW201400121A (zh) | 2014-01-01 |
MY172530A (en) | 2019-11-29 |
CN104203246A (zh) | 2014-12-10 |
JP2015514700A (ja) | 2015-05-21 |
CO7111317A2 (es) | 2014-11-10 |
EP3363500A1 (en) | 2018-08-22 |
MX369520B (es) | 2019-11-11 |
AU2013236960B2 (en) | 2017-11-23 |
CA2864073A1 (en) | 2013-09-26 |
NZ630011A (en) | 2016-12-23 |
TW201832767A (zh) | 2018-09-16 |
SG11201404921QA (en) | 2014-10-30 |
US20150038476A1 (en) | 2015-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA112288C2 (uk) | Склад антитіла, що специфічно зв'язує рецептор а іl-17, і терапевтичні режими | |
MX2019003467A (es) | Formulaciones y metodos para la administracion vaginal de antiprogestinas. | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
AR092177A1 (es) | Metodos para tratar o prevenir asma administrando un antagonista de il-4r | |
MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
MY188139A (en) | Sodium channel modulators for the treatment of pain | |
EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
PH12015500246A1 (en) | Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor | |
WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
EA201290171A1 (ru) | Вводимые перорально кортикостероидные композиции | |
NZ606765A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
EA201400002A1 (ru) | Способы лечения заболеваний сетчатки | |
EA201491614A1 (ru) | Способ лечения гинекологических заболеваний | |
MX2014000066A (es) | Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana. | |
EA201390417A1 (ru) | Антидиабетические твердые фармацевтические композиции | |
MX2015005993A (es) | Composiciones y metodos para el tratamiento de displasia ectodermica. | |
EA201591603A1 (ru) | Новые терапевтические комбинации миртазапина для применения при болевых расстройствах | |
CL2015003014A1 (es) | Composición farmacéutica que comprende 0,5-5 mg de (11?,17?)-17-hidroxi-11-[4-(metilsulfonil)fenil]-17-(pentafluoroetil)estra-4,9-dien-3-ona; forma de dosificación oral; uso para tratar y/o prevenir una enfermedad ginecológica, tal como, fibroides en el útero, endometriosis o hemorragias menstruales excesivas. | |
MX2016006375A (es) | Una combinacion de unidades de dosificacion para su uso en el tratamiento del parto prematuro. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |